Sahajanand Medical Technologies Limited (NSE:SMT)

Market Cap	48.70B
Revenue (ttm)	13.55B +32.2%
Net Income	698.05M +242.9%
EPS	6.93 +244.8%
Shares Out	98.37M
PE Ratio	71.43
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	328,901
Open	502.80
Previous Close	492.90
Day's Range	478.80 - 502.90
52-Week Range	344.00 - 565.75
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 5, 2026

About NSE:SMT

Sahajanand Medical Technologies Limited engages in the manufacture and distribution of Class III and Class C/D medical devices in India, Europe, rest of the Asia Pacific, Latin America, and the Middle East and Africa. The company provides vascular intervention products coronary stents and balloons used to diagnose or treat diseases of the blood vessels; structural heart products comprising trans-catheter aortic valves and occluders used to treat defects or abnormalities in the heart’s structure; and other products, such as renal stents, periphe...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 1,605
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SMT

Financial Performance

In fiscal year 2026, NSE:SMT's revenue was 12.11 billion, an increase of 18.11% compared to the previous year's 10.25 billion. Earnings were 652.85 million, an increase of 220.68%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 11, 2026

Data Sources Report a data error